Walgreens Boots Alliance, Inc. (WBA)
NEGATIVEFundamental
~0
Precio
$-
Capitalización Bursátil
-
Parte 1 · Cuánto vale la empresa
Resumen
No hay descripción disponible.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Datos financieros limitados disponibles (0% de las métricas). Las puntuaciones pueden no reflejar con precisión los fundamentos de esta empresa.
Balance y Liquidez
Ingresos
-
Beneficio Neto
-
Flujo de Caja Libre
-
Patrimonio Neto Total
-
Pasivo Total
-
Ratio de Liquidez
0.68
Cobertura de Intereses
-
Deuda/EBITDA
-
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Métricas de Valoración
Ratio P/E
-
ROE
-72.7%
Ratio P/B
-
P/FCF
-
Margen Bruto
-
ROIC
-
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
-
WACC
8.0%
ROIC − WACC
-
Criterios de Análisis Fundamental
Superado (0)
Fallido (0)
No disponible (1)
- Error fetching data
Piotroski F-Score
Preocupaciones financieras graves
Calidad de los Beneficios
Baja calidad: investigue la contabilidad
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Gobernanza
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for WBA, sourced from Markets Gazette.
- 6/9/2026NEUTRALBoots Owner in Talks on Possible $10 Billion Sale, FT Says
Walgreens Boots Alliance, the parent company of the UK health and beauty retailer Boots, is reportedly in discussions for a potential sale valued at approximately $10 billion. The Financial Times reports that potential suitors include the Weston family and Australian pharmacy group Sigma Healthcare Ltd. This news indicates a significant strategic move by WBA, potentially reshaping its portfolio. Investors will monitor the progress of these talks, as a sale could unlock value or signal a divestment of a key, albeit underperforming, asset.
- 4/2/2026POSITIVEWalgreens’ Private Equity Owner Plans to Double Pharmacy Chain’s Profits
The private equity owner of Walgreens has outlined ambitious plans to double the pharmacy chain's profitability within the coming years, following a substantial $10 billion acquisition. This strategic initiative, revealed by sources close to the deal, signals a strong conviction in Walgreens' turnaround potential. Investors will be closely watching the execution of these plans, which are expected to focus on operational efficiencies and market expansion. The news suggests a potential upside for the company's valuation, pending successful implementation of the private equity firm's growth strategy.
- 2/23/2026NEGATIVEWalgreens widens job cuts amid store closures
Walgreens Boots Alliance is escalating its restructuring efforts, announcing a new wave of job cuts and significant store closures. This action is part of a broader trend of distress within the U.S. retail pharmacy sector, highlighted by similar moves from competitors like CVS, which has laid off workers to focus on online delivery, and the bankruptcy of Rite Aid. Walgreens' strategy aims to cut costs and streamline its physical footprint to navigate a rapidly changing market and intense competitive pressure. Investors are closely watching to see if these drastic measures will be enough to reverse the negative trend and set the company back on a path to sustainable growth, amidst a landscape also marked by store closures from giants like Amazon.
via Markets Gazette